Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 13,827Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4AstraZeneca Canada Inc.

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Saxagliptin Hydrochloride

Brand Name : ONGLYZA

Patent Number : 2568391

Filing Date : 2005-05-26

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2025-05-26

Date Granted : 2013-05-14

blank

02

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Saxagliptin Hydrochloride

Brand Name : ONGLYZA

Patent Number : 2402894

Filing Date : 2001-03-05

Strength per Unit : 5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-03-05

Date Granted : 2012-04-17

blank

03

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Saxagliptin Hydrochloride

Brand Name : ONGLYZA

Patent Number : 2568391

Filing Date : 2005-05-26

Strength per Unit : 2.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2025-05-26

Date Granted : 2013-05-14

blank

04

arrow
2024 ACI Convention
Not Confirmed
arrow
2024 ACI Convention
Not Confirmed

Saxagliptin Hydrochloride

Brand Name : ONGLYZA

Patent Number : 2402894

Filing Date : 2001-03-05

Strength per Unit : 2.5 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2021-03-05

Date Granted : 2012-04-17

blank